• 1.

    Packaged facts. Rockville, Md: Publishing Division of Market-Research.com Inc, 2005.

  • 2.

    Oke S, Aghazadeh-Habashi A, Weese JS, et al. Evaluation of glucosamine levels in commercial equine oral supplements for joints. Equine Vet J 2006;38:9395.

    • Search Google Scholar
    • Export Citation
  • 3.

    Adebowale AO, Cox DS, Liang Z, et al. Analysis of glucosamine and chondroitin sulfate content in marketed products and the caco-2 permeability of chondroitin sulfate raw materials. JAMA 2000;3:3744.

    • Search Google Scholar
    • Export Citation
  • 4.

    Russell AS, Aghazadeh-Habashi A, Jamali F. Active ingredient constituency of commercially available glucosamine sulfate products. J Rheumatol 2002;29:24072409.

    • Search Google Scholar
    • Export Citation
  • 5.

    Boothe DM. Balancing fact and fiction of novel ingredients: definitions, regulations and evaluations. Vet Clin North Am Small Anim Pract 2004;34:738.

    • Search Google Scholar
    • Export Citation
  • 6.

    Zhou JZ, Waszkuc T, Mohammed R. Determination of glucosamine in raw materials and dietary supplements containing glucosamine sulfate and/or glucosamine hydrochloride by HPLC with FMOC-Su derivitization: collaborative study. J AOAC Int 2005;88:10481058.

    • Search Google Scholar
    • Export Citation
  • 7.

    McCarthy G, O'Donovan J, Jones B, et al. Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. Vet J 2006;174:5461.

    • Search Google Scholar
    • Export Citation
  • 8.

    Innes JF, Fuller CJ, Grover ER, et al. Randomised, double-blind, placebo-controlled parallel group study of P54FP for the treatment of dogs with osteoarthritis. Vet Rec 2003;152:457460.

    • Search Google Scholar
    • Export Citation
  • 9.

    Pollard B, Guilford WG, Ankenbauer-Perkins KL, et al. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. N Z Vet J 2006;54:114118.

    • Search Google Scholar
    • Export Citation
  • 10.

    Bui LM, Bierer TL. Improvement of arthritic signs in dogs fed green-lipped mussel (Perna canaliculus). J Nutr 2002;132:1634S1636S.

  • 11.

    Bui LM, Bierer TL. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs. Vet Ther 2003;4:397407.

    • Search Google Scholar
    • Export Citation
  • 12.

    Reichling J, Schmokel H, Fitzi J, et al. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweiz Arch Tierheilkd 2004;146:7179.

    • Search Google Scholar
    • Export Citation
  • 13.

    Mani S, Lawson JW. In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus. BMC Complement Altern Med 2006;6:1.

    • Search Google Scholar
    • Export Citation
  • 14.

    Treschow AP, Hodges LD, Wright PF, et al. Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol 2007;147:645656.

    • Search Google Scholar
    • Export Citation
  • 15.

    Budsberg SC, Bartges JW. Nutrition and osteoarthritis in dogs: does it help? Vet Clin North Am Small Anim Pract 2006;36:13071323.

  • 16.

    Johnston SA, Budsberg SC, Marcellin-Little DJ, et al. Clinician's update: supplement to NAVC clinician's brief. Canine osteoarthritis. Overview, therapies, & nutrition. Available at: clinicians-brief.com/uploads/docs/pdfs/supplements/hills.cu.oa.april05.p.pdf. Accessed Apr 13, 2009.

    • Search Google Scholar
    • Export Citation
  • 17.

    McPhee S, Hodges LD, Wright PF, et al. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol 2007;146:346356.

    • Search Google Scholar
    • Export Citation
  • 18.

    Halpern GM. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allerg Immunol (Paris) 2000;32:272278.

    • Search Google Scholar
    • Export Citation
  • 19.

    Moreau M, Dupuis J, Bonneau NH, et al. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec 2003;152:323329.

    • Search Google Scholar
    • Export Citation
  • 20.

    Aragon CL, Hofmeister EH, Budsberg SC. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc 2007;230:514521.

    • Search Google Scholar
    • Export Citation
  • 21.

    McNamara PS, Barr SC, Erb HN, et al. Hematologic, hemostatic, and biochemical effects in cats receiving an oral chondroprotective agent for 30 days. Vet Ther 2000;1:108117.

    • Search Google Scholar
    • Export Citation
  • 22.

    Johnson KA, Hulse DA, Hart RC, et al. Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage 2001;9:1421.

    • Search Google Scholar
    • Export Citation
  • 23.

    Hansen RA, Harris MA, Pluhar GE, et al. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. J Nutr Biochem 2008;19:101108.

    • Search Google Scholar
    • Export Citation
  • 24.

    Canapp SO Jr, McLaughlin RM Jr, Hoskinson JJ, et al. Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate. Am J Vet Res 1999;60:15521557.

    • Search Google Scholar
    • Export Citation
  • 25.

    Altinel L, Saritas ZK, Kose KC, et al. Treatment with unsaponifiable extracts of avocado and soybean increases TGF-B1 and TGF-B2 levels in canine joint fluid. Tohoku J Exp Med 2007;211:181186.

    • Search Google Scholar
    • Export Citation
  • 26.

    MacKenzie L, Holland P, McNabb P, et al. Complex toxin profiles in phytoplankton and greenshell mussels (Perna canaliculus), revealed by LC-MS/MS analysis. Toxicon 2002;40:13211330.

    • Search Google Scholar
    • Export Citation
  • 27.

    Alfonso C, Alfonso A, Vieytes MR, et al. Quantification of yessotoxin using the fluorescence polarization technique and safety study of the adequate extraction procedure. Anal Biochem 2005;344:266274.

    • Search Google Scholar
    • Export Citation
  • 28.

    Chiu ST, Lam FS, Tze WL, et al. Trace metals in mussels from mariculture zones, Hong Kong. Chemosphere 2000;41:101108.

  • 29.

    So MK, Zhang X, Giesy JP, et al. Organochlorines and dioxin-like compounds in green-lipped mussels Perna viridis from Hong Kong mariculture zones. Mar Pollut Bull 2005;51:677687.

    • Search Google Scholar
    • Export Citation
  • 30.

    Hewitt J, Greening GE. Survival and persistence of norovirus, hepatitis A virus, and feline calicivirus in marinated mussels. J Food Prot 2004;67:17431750.

    • Search Google Scholar
    • Export Citation
  • 31.

    Marshall PD, Poddar S, Tweed EM, et al. Clinical inquiries: do glucosamine and chondroitin worsen blood sugar control in diabetes? J Fam Pract 2006;55:10911093.

    • Search Google Scholar
    • Export Citation
  • 32.

    Scroggie DA, Albright A, Harris MD. The effect of glucosaminechondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus. Arch Intern Med 2003;163:15871590.

    • Search Google Scholar
    • Export Citation
  • 33.

    Muniyappa R, Karne RJ, Jall G, et al. Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects. Diabetes 2006;55:31423150.

    • Search Google Scholar
    • Export Citation
  • 34.

    Pham T, Cornea A, Blick K, et al. Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance. Am J Med Sci 2007;333:333339.

    • Search Google Scholar
    • Export Citation
  • 35.

    Echard BW, Talpur NA, Funk KA, et al. Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats. Mol Cell Biochem 2001;225:8591.

    • Search Google Scholar
    • Export Citation
  • 36.

    McNamara PS, Barr SC, Erb HN. Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am J Vet Res 1996;57:13901394.

    • Search Google Scholar
    • Export Citation
  • 37.

    Kirk CA, Jewell DE, Lowry SR. Effects of sodium chloride on selected parameters in cats. Vet Ther 2006;7:3346.

  • 38.

    Buranakarl C, Mathur S, Brown SA. Effects of dietary sodium chloride on renal function and blood pressure in cats with normal and reduced renal function. Am J Vet Res 2004;65:620627.

    • Search Google Scholar
    • Export Citation

Advertisement

Indications and contraindications for the use of orally administered joint health products in dogs and cats

Stacey L. Oke DVM, MS1
View More View Less
  • 1 Rolling Thunder Scientific, 34 Lasby Ln, Acton, ON L7J 2W9, Canada.

Contributor Notes

Dr. Oke is a paid consultant of Nutramax Laboratories Incorporated.